Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13 » default

Pharmacogenomics and Personalized Medicine


Archive: Volume 13, 2020

HMGA2 Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study

Li L, Zhuo Z, Yang Z, Zhu J, He X, Yang Z, Zhang J, Xin Y, He J, Zhang T

Pharmacogenomics and Personalized Medicine 2020, 13:51-57

Published Date: 11 February 2020

Towards Precision Medicine in Systemic Lupus Erythematosus

Lever E, Alves MR, Isenberg DA

Pharmacogenomics and Personalized Medicine 2020, 13:39-49

Published Date: 4 February 2020

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV

Pharmacogenomics and Personalized Medicine 2020, 13:29-37

Published Date: 23 January 2020

The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children

Pavlovic D, Budic I, Jevtovic Stoimenov T, Stokanovic D, Marjanovic V, Stevic M, Slavkovic M, Simic D

Pharmacogenomics and Personalized Medicine 2020, 13:13-27

Published Date: 17 January 2020

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine

Chamnanphon M, Gaedigk A, Puangpetch A, Pasomsub E, Chantratita W, Longley RJ, Sattabongkot J, Chariyavilaskul P, Sukasem C

Pharmacogenomics and Personalized Medicine 2020, 13:1-12

Published Date: 10 January 2020